drugset / Trial / NCT00719563

American Ginseng in Treating Patients With Fatigue Caused by Cancer

NCT00719563

RandomizedParallel-groupDouble-blindSupportive care

Summary

RATIONALE: American ginseng may reduce fatigue in patients with cancer. It is not yet known whether American ginseng is more effective than a placebo in treating cancer-related fatigue. PURPOSE: This randomized phase III trial is studying American ginseng to see how well it works in treating patients with fatigue caused by cancer.

Timeline

Start
2008-10
Primary completion
2011-08
Completion
2013-08

Publications

  • Results Barton DL, Liu H, Dakhil SR, et al.: Phase III evaluation of American ginseng (panax quinquefolius) to improve cancer-related fatigue: NCCTG trial N07C2. [Abstract] J Clin Oncol 30 (Suppl 15): A-9001, 2012.

Drugs

EvaluationDrugModalityDoseRoute
Subject American ginseng Unknown Oral